- Home
- PRE vs COYA Comparison
PRE vs COYA Comparison
Compare PRE & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRE | COYA |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.3M | 126.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | PRE | COYA |
|---|---|---|
| Price | $15.94 | $4.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $32.00 | $15.80 |
| AVG Volume (30 Days) | 162.2K | ★ 266.4K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,079,000.00 | $3,987,706.00 |
| Revenue This Year | $219.28 | $69.95 |
| Revenue Next Year | $124.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 201.54 | N/A |
| 52 Week Low | $3.10 | $4.45 |
| 52 Week High | $18.48 | $8.29 |
Technical Indicators
Market Signals| Indicator | PRE | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 30.12 |
| Support Level | $14.66 | $4.45 |
| Resistance Level | $16.96 | $5.50 |
| Average True Range (ATR) | 0.93 | 0.41 |
| MACD | -0.16 | -0.07 |
| Stochastic Oscillator | 42.44 | 15.19 |
Price Performance
Historical ComparisonAbout PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.